Peptide record

TPDB46962

ACE inhibitor (b-CN 193-198) ACE inhibitors Antihypertensive standard
6 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB46962
ACE inhibitor (b-CN 193-198)
ACE inhibitors Antihypertensive
Cardiometabolic peptides
FermFooDB pep-lab Peptipedia AHTPDB AHTpin
standard
No
A 6-aa standard-residue multi-activity (ACE inhibitors and Antihypertensive) peptide sequence curated from FermFooDB, pep-lab, Peptipedia, and other sources, with an available 3D structural model.
Sequence
YQQPVL
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C35H54N8O10
ARNDCEGHIKMFSTW
Q
746.86
5.94
0
0
3
-0
0.38
-0.317
113.33
Mammalian: 2.8 hour Yeast: 10 min E.coli: 2 min
1490
2.00
3
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
0
E
2
Q
0
G
0
H
0
I
1
L
0
K
0
M
0
F
1
P
0
S
0
T
0
W
1
Y
1
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 2 G: 0 H: 0 I: 0 L: 1 K: 0 M: 0 F: 0 P: 1 S: 0 T: 0 W: 0 Y: 1 V: 1
Chemical Descriptors
6 reviewed residue count
C35H54N8O10 sequence-only estimate (linear, free termini)
746.86 sequence-only estimate (linear, free termini)
5.94 sequence-only estimate (linear, free termini)
-0 sequence-only estimate (linear, free termini)
0.38 sequence-only estimate (linear, free termini)
-0.317 sequence-only estimate (linear, free termini)
746.8487 Activity
746.3950 Activity
Evidence Records 2 records
Evidence 1 Activity

Activity

IC50
ACE inhibitors
280.00 µM
ACE inhibitor
ah

Source & Reference

FermFooDB
Pihlanto-Leppala A., Rokka T., Korhonen H.
Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins. Int. Dairy Journal 8, 325-331(1998)
1998
Journal

Other

6
BIOPEP-UWM database of bioactive peptides SMILES: [H][C@](N)(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CCC(N)=O)C(=O)N[C@@]([H])(CCC(N)=O)C(=O)N1CCC[C@@]1([H])C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CC(C)C)C(O)=O InChI=1S/C35H54N8O10/c1-18(2)16-25(35(52)53)41-33(50)29(19(3)4)42-32(49)26-6-5-15-43(26)34(51)24(12-14-28(38)46)40-31(48)23(11-13-27(37)45)39-30(47)22(36)17-20-7-9-21(44)10-8-20/h7-10,18-19,22-26,29,44H,5-6,11-17,36H2,1-4H3,(H2,37,45)(H2,38,46)(H,39,47)(H,40,48)(H,41,50)(H,42,49)(H,52,53)/t22-,23-,24-,25-,26-,29-/m0/s1 InChIKey=VDWSKVHLUNWXCP-WTWMNNMUSA-N
Evidence 2 Activity

Activity

IC50
Antihypertensive
280.00 µM
ACE inhibitor
ah

Source & Reference

AHTPDB FermFooDB
Pihlanto-Leppala A., Rokka T., Korhonen H.
Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins. Int. Dairy Journal 8, 325-331(1998)
1998
Journal

Other

Source Activity Label Source Definition
Antihypertensive
AHTPDB manually curated experimentally validated antihypertensive peptide annotation.
6
BIOPEP-UWM database of bioactive peptides SMILES: [H][C@](N)(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CCC(N)=O)C(=O)N[C@@]([H])(CCC(N)=O)C(=O)N1CCC[C@@]1([H])C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CC(C)C)C(O)=O InChI=1S/C35H54N8O10/c1-18(2)16-25(35(52)53)41-33(50)29(19(3)4)42-32(49)26-6-5-15-43(26)34(51)24(12-14-28(38)46)40-31(48)23(11-13-27(37)45)39-30(47)22(36)17-20-7-9-21(44)10-8-20/h7-10,18-19,22-26,29,44H,5-6,11-17,36H2,1-4H3,(H2,37,45)(H2,38,46)(H,39,47)(H,40,48)(H,41,50)(H,42,49)(H,52,53)/t22-,23-,24-,25-,26-,29-/m0/s1 InChIKey=VDWSKVHLUNWXCP-WTWMNNMUSA-N
Additional Detail Fields 1 fields
6